Asia Pac Allergy. 2018 Jan;8(1):e5. English. Published online Jan 24, 2018. https://doi.org/10.5415/apallergy.2018.8.e5 |
Yukako Seo,1 Manabu Nonaka,1 Yukie Yamamura,1 Ruby Pawankar,2 and Etsuko Tagaya3 | |
1Department of Otolaryngology, Tokyo Women’s Medical University, Tokyo 162-8666, Japan. | |
2Department of Pediatrics, Nippon Medical School, Tokyo 113-0022, Japan. | |
3First Department of Medicine, Tokyo Women’s Medical University, Tokyo 162-8666, Japan. | |
Correspondence to: Manabu Nonaka. Department of Otolaryngology, Tokyo Women’s Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan. Tel: +81-3-3353-8111 (ext. 28531), Fax: +81-3-5269-7617, | |
Abstract
| |
Background
Eosinophilic otitis media (EOM) is often associated with comorbid asthma. The middle ear cavity is part of the upper airway. Therefore, EOM and asthma can be considered to be a crucial part of the “one airway, one disease” phenomenon. Based on the concept of one airway, one disease in the context of allergic rhinitis and asthma, optimal level of inhalation therapy for better asthma control leads to improvement in allergic rhinitis.
|